The rules for Current Good Manufacturing Practice (cGMP) Requirements for Combination Products were issued by the FDA in 2013. Existing Quality Systems can stay in place, but new requirements are necessary for the components not already addressed. This is where Regulatory Compliance Associates® can support your team in various scenarios:
When adding a Device to Existing Drug or Biologic Product:
|
When adding a Drug or Biologic to a Device Product:
|